Ga-68 THP-PSMA

N/A

Report date: 2025/11/20 13:28:22
NME

Base Information

Drug NameGa-68 THP-PSMA
Drug Alias Name(68)Ga-THP-PSMA68Ga-THP-PSMA[68Ga]THP-PSMA PET/CT[68Ga]Tris(hydroxypyridinone)(THP)-PSMAGa-68-THP-PSMA +[10] 
ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radionuclide Drug Conjugates +[4] 
Mechanisms of ActionPositron-emission tomography enhancersEmission-computed tomography enhancersRadionuclide imaging enhancers
TargetsNot applicable
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKing'S College London
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTheragnostics LtdAdvanced Accelerator Applications Sa
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A